Rezultati - Joseph Buscema

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

    Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial od Mansoor Raza Mirza, Benedict B. Benigno, Anne Dørum, Sven Mahner, Paul Bessette, Isabel Bover Barceló, Dominique Berton-Rigaud, Jonathan A. Ledermann, B.J. Rimel, Jørn Herrstedt, Susie Lau, Andreas du Bois, Antonio Casado, Elsa Kalbacher, Joseph Buscema, Domenica Lorusso, Ignace Vergote, Tally Levy, P. Wang, Floris A. de Jong, Dhiraj Gupta, Ursula A. Matulonis

    Izdano 2020
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer

    Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer od Gerald S. Falchook, Robert L. Coleman, A. Roszak, Kian Behbakht, Ursula A. Matulonis, Isabelle Ray‐Coquard, Piotr Sawrycki, Linda Duska, William P. Tew, Sharad Ghamande, Anne Lesoin, Peter E. Schwartz, Joseph Buscema, Michel Fabbro, Alain Lortholary, Barbara A. Goff, Razelle Kurzrock, Lainie P. Martin, Heidi J. Gray, Siqing Fu, Emily Sheldon‐Waniga, Huamao Mark Lin, Karthik Venkatakrishnan, Xiaofei Zhou, E. Jane Leonard, Russell J. Schilder

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

    Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer od Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt, Amit M. Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A. Ledermann, Domenica Lorusso, Ignace Vergote, Noa Ben-Baruch, Christian Marth, Radosław Mądry, René dePont Christensen, Jonathan S. Berek, Anne Dørum, Anna V. Tinker, Andreas du Bois, Antonio González-Martı́n, Philippe Follana, Benedict B. Benigno, Per Rosenberg, Lucy Gilbert, B.J. Rimel, Joseph Buscema, John Balser, Shefali Agarwal, Ursula A. Matulonis

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

    Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer od Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt, Amit M. Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A. Ledermann, Domenica Lorusso, Ignace Vergote, Noa Ben-Baruch, Christian Marth, Radosław Mądry, René dePont Christensen, Jonathan S. Berek, Anne Dørum, Anna V. Tinker, Andreas du Bois, Antonio González‐Martín, Philippe Follana, Benedict B. Benigno, Per Rosenberg, Lucy Gilbert, B.J. Rimel, Joseph Buscema, John Balser, Shefali Agarwal, Ursula A. Matulonis

    Izdano 2017
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

    Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer od Kathleen N. Moore, Antoine Angelergues, Gottfried E. Konecny, Yolanda García García, Susana Banerjee, Domenica Lorusso, Jung‐Yun Lee, John W. Moroney, Nicoletta Colombo, A. Roszak, Jacqueline M. Tromp, Tashanna Myers, Jeong‐Won Lee, Mario Beiner, Casey Cosgrove, David Cibula, Lainie P. Martin, Renaud Sabatier, Joseph Buscema, Purificación Estévez-García, Lan Coffman, Shibani Nicum, Linda Duska, Sandro Pignata, Fernando Gálvez, Yuemei Wang, Michael Method, Anna Berkenblit, Diana Bello Roufai, Toon Van Gorp

    Izdano 2023
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study

    Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study od Ignace Vergote, Larry J. Copeland, Toon Van Gorp, Annouschka Laenen, Giovanni Scambia, Premal H. Thaker, David Cibula, Nicoletta Colombo, Jayanthi Lea, Antonio González-Martı́n, Jacob Korach, Jalid Sehouli, Bradley J. Monk, Viola Heinzelmann‐Schwarz, Regina Berger, Joseph Buscema, Susie Lau, Radosław Mądry, Hannelore Denys, Jessica Thomes Pepin, Vanda Salutari, Andrea Bagaméri, Antonio Ardizzoia, Stéphanie Henry, Sabrina Chiara Cecere, Martin Hruda, David A. Iglesias, Luís Manso, Ayelet Shai, David M. O’Malley

    Izdano 2025
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study

    Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5... od Vicky Makker, José Alejandro Pérez Fidalgo, Giorgio Valabrega, Erika Hamilton, Toon Van Gorp, Jalid Sehouli, Klaudia Regináčová, Debra L. Richardson, Tamar Perri, Amit M. Oza, David S. Miller, Eva Maria Guerra Alía, Ugo De Giorgi, Stéphanie Henry, Daniel L. Spitz, Pauline Wimberger, Markéta Bednaříková, Hye Sook Chon, Jerónimo Martínez, Carmela Pisano, Jonathan S. Berek, Ignacio Romero, Giovanni Scambia, Lorena Fariñas-Madrid, Joseph Buscema, Fabienne Schochter, Kai Li, Pratheek Kalyanapu, Christopher J. Walker, Ignace Vergote

    Izdano 2024
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial

    Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial od M.A. Powell, Line Bjørge, Lyndsay Willmott, Z. Novák, D. Black, L. Gilbert, S. Sharma, G. Valabrega, Lisa M. Landrum, Martina Gropp‐Meier, A. Stuckey, Ingrid Boere, Michael A. Gold, Yakir Segev, S.E. Gill, Christine Gennigens, Alexandra Sebastianelli, Mark S. Shahin, Bhavana Pothuri, B.J. Monk, Joseph Buscema, R.L. Coleman, B.M. Slomovitz, Kari L. Ring, T.J. Herzog, Morad Marco Balas, M. Grimshaw, S. Stevens, Dominic W. Lai, Carolyn K. McCourt, MR Mirza

    Izdano 2024
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

    Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer od Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz, René dePont Christensen, Zoltán Novàk, Destin Black, Lucy Gilbert, Sudarshan Sharma, Giorgio Valabrega, Lisa M. Landrum, Lars Hanker, Ashley Stuckey, Ingrid Boere, Michael A. Gold, Annika Auranen, Bhavana Pothuri, David Cibula, Carolyn K. McCourt, Francesco Raspagliesi, Mark S. Shahin, Sarah Gill, Bradley J. Monk, Joseph Buscema, Thomas J. Herzog, Larry J. Copeland, Min Tian, Zangdong He, Shadi Stevens, Eleftherios Zografos, Robert L. Coleman, Matthew A. Powell

    Izdano 2023
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

    Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial od Ignace Vergote, Giovanni Scambia, David M. O’Malley, Ben Van Calster, Sang‐Yoon Park, Josep M. del Campo, Werner Meier, Aristotelis Bamias, Nicoletta Colombo, Robert M. Wenham, Al Covens, Christian Marth, Mansoor Raza Mirza, Judith R. Kroep, Haijun Ma, Cheryl A. Pickett, Bradley J. Monk, Ignace Vergote, Giovanni Scambia, Sangyoon Park, Yong Sang Song, Yulia Makarova, Joshua Trinidad, Hys Ngan, Aristotelis Bamias, Gerasimos Aravantinos, Joo‐Hyun Nam, Vera Gorbunova, Л. И. Крикунова, Bae Duk‐Soo, José Ángel Arranz Arija, Mansoor Raza Mirza, Claudio Zamagni, Christos N. Papandreou, Francesco Raspagliesi, Alla Lisyanskaya, Ana Oaknin Benzaquen, Germana Tognon, Eugenia Ortega, Antonio Casado, Joseph Buscema, Andrew Green, Robert A. Burger, Dina Sakaeva, Andrés Redondo, Shekhar Ghamande, Laurel A. King, Edgar Petru, Ulla Peen, Satoshi Takeuchi, Kimio Ushijima, Antonio González‐Martín, Scott Kamelle, Michael E. Carney, Christian Marth, Frédéric Forget, J. Bentley, Jalid Sehouli, Nicoletta Colombo, Paolo Zola, Hidenori Kato, Natalya Fadeeva, Evgeny Gotovkin, Vladimir Vladimirov, Margarita Romeo, Eva Guerra Alía, Mark S. Shahin, Snehalkumar M Bhoola, Krishnansu S. Tewari, Daniel M. Anderson, Brigitte Honhon, J. Pelgrims, Amit M. Oza, Jesus Garcia-Donas Jimenez, Vincent Hansen, David M. O’Malley, Ivor Benjamin, Vincent Renard, Heidi Van den Bulck, Werner Meier, Claudia Haenle, G. Koumakis, Harushige Yokota, В.М. Попов, William E. Bradley, Robert M. Wenham, Robert H. Reid, Donna McNamara, Richard D. Friedman, Joyce N. Barlin, Nicola M. Spirtos, Julia Chapman, P. Sevelda, Manon Huizing, C. Lamot, Frédéric Goffin, Lionel D. Hondt, Allan Covens, Silvana Spadafora, Beate Rautenberg

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: